Tokai Pharmaceuticals To Present At The Oppenheimer 26th Annual Healthcare Conference

BOSTON--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases, today announced that Jodie Morrison, President and Chief Executive Officer, will present at the Oppenheimer 26th Annual Healthcare Conference on Wednesday, December 9, 2015 at 9:10am ET, at The Westin Grand Central in New York City.